Suppr超能文献

NUP98::NSD1 和 FLT3/ITD 共表达是儿科急性髓系白血病患者预后不良的独立预测因子。

NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients.

机构信息

Department of Pediatrics, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-Sen University, Guangzhou, China.

出版信息

BMC Pediatr. 2024 Aug 24;24(1):547. doi: 10.1186/s12887-024-05007-3.

Abstract

OBJECTIVE

Patients who carry NUP98::NSD1 or FLT3/ITD mutations are reported to have poor prognosis. Previous studies have confidently reported that the poor outcome in younger AML patients is owning to dual NUP98::NSD1 and FLT3/ITD positivity, with a high overlap for those two genetic lesions. In this study, we assessed the prognostic value of the presence of both NUP98::NSD1 and FLT3/ITD in pediatric AML patients.

METHODS

We screened a large cohort of 885 pediatric cases from the COG-National Cancer Institute (NCI) TARGET AML cohort and found 57 AML patients with NUP98 rearrangements.

RESULTS

The frequency of NUP98 gene fusion was 10.8% in 529 patients. NUP98::NSD1 fusion was the most common NUP98 rearrangement, with a frequency of 59.6%(34 of 57). NUP98::NSD1 -positive patients who carried FLT3/ITD mutations had a decreased CR1 or CR2 rate than those patients carried FLT3/ITD mutation alone (P = 0.0001). Moreover, patients harboring both NUP98::NSD1 fusion and FLT3/ITD mutation exhibited inferior event-free survival (EFS, P < 0.001) and overall survival (OS, P = 0.004) than patients who were dual negative for these two genetic lesions. The presence of only NUP98::NSD1 fusion had no significant impact on EFS or OS. We also found that cases with high FLT3/ITD AR levels ( > = 0.5) with or without NUP98::NSD1 had inferior prognosis. Multivariate analysis demonstrated that the presence of both NUP98::NSD1 and FLT3/ITD was an independent prognostic factors for EFS (hazard ratio: 3.2, P = 0.001) in patients with pediatric AML. However, there was no obvious correlation with OS (hazard ratio: 1.3, P = 0.618). Stem cell transplantation did not improve the survival rate of cases with NUP98 fusion or NUP98::NSD1 AML in terms of EFS or OS.

CONCLUSION

Presence of both NUP98::NSD1 and FLT3/ITD was found to be an independent factor for dismal prognosis in pediatric AML patients. Notably, lack of FLT3/ITD mutations in NUP98::NSD1 -positive patients did not retain its prognostic value.

摘要

目的

携带 NUP98::NSD1 或 FLT3/ITD 突变的患者被报道预后不良。先前的研究有信心地报告说,年轻 AML 患者的不良预后归因于双重 NUP98::NSD1 和 FLT3/ITD 阳性,这两种遗传病变有很高的重叠。在这项研究中,我们评估了 NUP98::NSD1 和 FLT3/ITD 同时存在于儿科 AML 患者中的预后价值。

方法

我们对 COG-National Cancer Institute (NCI) TARGET AML 队列中的 885 例儿科大病例进行了筛查,发现 57 例 AML 患者存在 NUP98 重排。

结果

在 529 例患者中,NUP98 基因融合的频率为 10.8%。NUP98::NSD1 融合是最常见的 NUP98 重排,频率为 59.6%(57 例中的 34 例)。NUP98::NSD1 阳性且携带 FLT3/ITD 突变的患者与仅携带 FLT3/ITD 突变的患者相比,CR1 或 CR2 率降低(P = 0.0001)。此外,同时携带 NUP98::NSD1 融合和 FLT3/ITD 突变的患者的无事件生存(EFS,P < 0.001)和总生存(OS,P = 0.004)均低于这两种遗传病变均为阴性的患者。仅存在 NUP98::NSD1 融合对 EFS 或 OS 没有显著影响。我们还发现,无论是否存在 NUP98::NSD1,具有高 FLT3/ITD AR 水平( > = 0.5)的病例预后较差。多变量分析表明,在儿科 AML 患者中,同时存在 NUP98::NSD1 和 FLT3/ITD 是 EFS(危险比:3.2,P = 0.001)的独立预后因素。然而,与 OS 无明显相关性(危险比:1.3,P = 0.618)。干细胞移植并未改善 NUP98 融合或 NUP98::NSD1 AML 病例的 EFS 或 OS 生存率。

结论

同时存在 NUP98::NSD1 和 FLT3/ITD 被发现是儿科 AML 患者预后不良的独立因素。值得注意的是,在 NUP98::NSD1 阳性患者中缺乏 FLT3/ITD 突变并未保留其预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c23/11344362/2b0134caf6fa/12887_2024_5007_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验